References
- References
- CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–39.
- Savi P, Heilmann E, Nurden P, Laplace MC, Bihour C, Kiefer G, et al. Clopidogrel: an antithrombotic drug acting on the ADP-dependent activation pathway of human platelets. Clin Appl Thromb Hemost 1996;2:35–42.
- Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971;231: 232–5.
- Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979;77:761–7.
- Davenport HW, Warner HA, Code CF. Functional significance of gastric mucosal barrier to sodium. Gastroenterology 1964;47: 142–52.
- Bogousslavsky J. Lower gastrointestinal bleeding with clopidogrel compared with aspirin. Cerebrovasc Dis 1998;8 Suppl 4:43.
- Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ 1990;300:278–84.
- Lanza FL, Royer GL Jr, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980;303:136–8.
- Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal antiinflammatory agents. Am J Med 1984;77:19–24.
- Simon B, Kleinsorge H, Muller P. Vergleich der gastroduodenalen verträglichkeit von ticlopidine und acetylsalicylsdure. Dtsch Med Wochenschr 1993;188:1146–9.
- Hirsh J, Dalen JE, Fuster V, Harker L, Patrono C, Roth GJ. Aspirin and other platelet-active drugs: the relationship between dose, effectiveness and side-effects. Chest 1995;108 Suppl: S247–57.
- Stalnikowicz-Darvasi R. Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events: a critical analysis. J Clin Gastroenterol 1995;21:13–6.
- Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310:827–30.
- Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric coated or buffered product. Lancet 1996;348:1413–6.
- Dyken ML. Aspirin dose in secondary prevention of stroke. Cerebrovasc Dis 1998;8:361–2.
- Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81–106.
- Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effect of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;361:1755–62.
- Grossman CM. NSAIDs and gut toxicity. Lancet 1994;344:57.